Navigation Links
Generex Announces Presentations of Novel Vaccine Strategies
Date:9/16/2010

cturing, and use.  The Company is continuing its work toward developing synthetic vaccines for both pandemic and seasonal influenza strains.

About Generex Biotechnology Corporation

Generex is engaged in the research, development and commercialization of drug delivery systems and technologies.  Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs).  The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device.  The Company's flagship product, buccal insulin (Generex Oral-lyn™), which has been approved in India, Lebanon, Algeria, and Ecuador for the treatment of subjects with Type-1 and Type-2 diabetes, is in Phase III clinical trials at several sites around the world.  Antigen Express, Inc. is a wholly owned subsidiary of Generex.  The core platform technologies of Antigen Express comprise immunotherapeutics for the treatment of malignant, infectious, allergic, and autoimmune diseases.  For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.

Safe Harbor Statement

This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements can be identified by introductory words such as "expects," "plans," "intends," "believes," "will," "estimates," "forecasts," "projects," or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts.  Forward-loo
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
2. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 Amgen (NASDAQ: AMGN ) will ... Conference on Thursday, May 30, 2013, at the Westin Boston ... a.m. Eastern Daylight Time. Arvind Sood , ... the conference. Live audio of the presentation can be accessed ... under Investors. A replay of the webcast will also be ...
(Date:5/23/2013)... , May 23, 2013  A recently published ... Houston, Texas , demonstrates that 3D ... increasing cancer detection. The study, "Implementation ... Observational Study," was led by Stephen L. ... issue of the American Journal of Roentgenology ...
(Date:5/23/2013)... Anthem Blue Cross patients with HIV/AIDS may ... to obtain their medications by mail order under a ... LLC.  The lawsuit, filed in January ... mandatory mail order program announced late last year illegally ... "This settlement brings to a close a nerve-racking ...
Breaking Medicine Technology:First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3
(Date:5/25/2013)... 25, 2013 This week idcloak Technologies releases ... Facebook in countries where the site is blocked. When ... faces none of the site compatibility problems associated with regular ... explains how a user may apply IP Port proxies to ... benefits of doing so are. , “When a user takes ...
(Date:5/25/2013)... Imagine running the air conditioner with the ... air and wasted energy! If the home has a folding ... clothes dryer, that may be just what is occurring in ... holes waste energy in the form of higher energy bills. ... in the home. , Drafts occur through the small cracks ...
(Date:5/25/2013)... May 25, 2013 It's not astonishing ... the year. The demands are endless, from family, friends ... buy, children who want more than their parents can ... after holiday season, comes graduations, birthdays, anniversaries and it ... some point gift ideas become tired and income can’t ...
(Date:5/25/2013)... Chandler, AZ (PRWEB) May 25, 2013 ... whitening service page in partnership with JD Media Surge, ... whitening methods are now available and, depending on the ... home. During a routine visit, the best method will ... whitening is performed during a visit. A special peroxide-based ...
(Date:5/25/2013)... Communities of Distinction TV announces May air ... media market in the United States with almost three million ... Texas and a major convention city. Ft. Worth is known ... is home to many major museums. Both cities offer a ... arts. Residents and locals will be able to watch the ...
Breaking Medicine News(10 mins):Health News:idcloak Launches Proxy Web Browser for Blocked Facebook Users 2Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 2Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 3Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 4Health News:TheBeautyPlace.com Debuts Their Brand New Beauty Kits 2Health News:Chandler Dentist Launches Teeth Whitening Service Page on Website in Partnership with JD Media Surge, LLC 2Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2
... class of drugs for treating,type 2 diabetes is under ... for Clinical Evaluative Sciences (ICES) finds that drugs such,as ... and death., Published in the December 12th issue ... drugs including rosiglitazone (Avandia) and,pioglitazone (Actos) in the first ...
... Early identification of adverse effects of drugs before they ... therapeutics, as unexpected effects account for a third of ... researchers at the University of California, San Diego (UCSD) ... identify potential side effects of pharmaceuticals, and have used ...
... -- In as many as one in five people ... blood around the body, some degree of backward leakage ... mitral regurgitation (MR). When sufficiently severe, MR causes buildup ... breathing (dyspnea, or "shortness of breath"), a serious condition ...
... predictor of heart disease, Britsh study says , TUESDAY, Dec. ... risk factor for heart disease, say British researchers who also ... of heart disease risk than waist measurement alone. , ... , included 24,508 men and women, ages 45 to 79, ...
... achievements place the field of microresonators at the ... issue of Optics Express, papers explore advanced silicon ... applications and the longest photon lifetime in a ... to Dr. Vasily Astratov from the University of ...
... is a familiar scenario experienced around the world: an outbreak ... one knows where it came from or how to stop ... people are affected, most often the very old and the ... fall ill, and people who were weak or unwell may ...
Cached Medicine News:Health News:More evidence suggests diabetes drug may be dangerous 2Health News:More evidence suggests diabetes drug may be dangerous 3Health News:New computational technique can predict drug side effects 2Health News:Exercise testing may help predict seriousness of mitral regurgitation 2Health News:Abdominal Fat Tied to High Risk for Coronary Trouble 2Health News:IBM reports milestone in silicon nanophotonics 2Health News:Scientists seek to assess the microbial risks in the water we drink 2Health News:Scientists seek to assess the microbial risks in the water we drink 3
... SofPort Advanced Optics Aspheric Lens System ... one IOL all your cataract patients ... vision quality and contrast sensitivity. With ... AO should consistently deliver superior optical ...
... Defibrillator was designed to be as easy ... and shares many of its features, including ... Philips HeartStart Home Defibrillator is an automated ... home use by untrained users. Although small ...
... Brilliance 64-channel configuration breaks through previous ... volume, thin-slice coverage to improve diagnostic ... ,With 40mm of thin-slice coverage, the ... allowing for unprecedented coronary artery evaluation. ...
Designed to meet the demanding requirements of scientific and laboratory,applications. Special cabinet incorporates industrial quality with a,heavy duty refrigeration system to maintain your valu...
Medicine Products: